Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Marpai ( (MRAI) ) has provided an update.
On February 13, 2026, Marpai, Inc. issued a $410,000 promissory note to Chief Executive Officer Damien Lamendola at a 12% annual interest rate, maturing April 11, 2026, and on March 9, 2026 it issued a second $250,000 note to him on the same terms maturing May 10, 2026. On April 29, 2026, Marpai and Lamendola agreed to extend the maturity dates of both notes, including all outstanding principal and interest, to September 1, 2026 while leaving all other terms unchanged, a move that eases near-term liquidity pressures and slightly lengthens the company’s short-term insider financing horizon.
The extension of these insider notes signals a continued willingness by Marpai’s CEO to support the company’s funding needs while deferring repayment, which may offer short-term financial flexibility but underscores the firm’s reliance on related-party debt. For stakeholders, the revised September 2026 maturities reduce immediate refinancing or repayment risk, potentially stabilizing the company’s cash planning over the next several months.
Spark’s Take on MRAI Stock
According to Spark, TipRanks’ AI Analyst, MRAI is a Neutral.
The score is weighed down primarily by weak financial performance (shrinking revenue, large losses, negative equity, and ongoing cash burn) and a bearish technical trend (price below all major moving averages with negative MACD). Valuation offers limited support due to negative earnings and no dividend, while the earnings call/corporate financing actions show some operational progress but also reinforce near-term liquidity risk.
To see Spark’s full report on MRAI stock, click here.
More about Marpai
Marpai, Inc. operates in the health benefits and insurance administration sector, focusing on managing self-funded health plans for employers. The company leverages data and technology-driven solutions to optimize healthcare spending and improve plan performance for its clients in the U.S. employer-sponsored benefits market.
Average Trading Volume: 65,843
Technical Sentiment Signal: Sell
Current Market Cap: $6.83M
For a thorough assessment of MRAI stock, go to TipRanks’ Stock Analysis page.